330 related articles for article (PubMed ID: 3041817)
1. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
[TBL] [Abstract][Full Text] [Related]
3. Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patients.
Gucalp R; Lia S; McKitrick JC; Wiernik PH
Am J Med; 1988 Jul; 85(1A):31-5. PubMed ID: 3041816
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Mortimer J; Miller S; Black D; Kwok K; Kirby WM
Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679
[TBL] [Abstract][Full Text] [Related]
5. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
[TBL] [Abstract][Full Text] [Related]
6. Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.
Jones P; Bodey GP; Rolston K; Fainstein V; Riccardi S
Am J Med; 1988 Jul; 85(1A):3-8. PubMed ID: 3400680
[TBL] [Abstract][Full Text] [Related]
7. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Winston DJ; Ho WG; Bruckner DA; Champlin RE
Ann Intern Med; 1991 Dec; 115(11):849-59. PubMed ID: 1952471
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
[TBL] [Abstract][Full Text] [Related]
11. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
[TBL] [Abstract][Full Text] [Related]
13. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
[TBL] [Abstract][Full Text] [Related]
14. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
16. A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients.
Kibbler CC; Prentice HG; Sage RJ; Hoffbrand AV; Brenner MK; Mannan P; Warner P; Bhamra A; Noone P
J Antimicrob Chemother; 1989 May; 23(5):759-71. PubMed ID: 2668246
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin plus aztreonam for treatment of neutropenic fever.
Takeuchi M; Tanizawa A; Mayumi M
Pediatr Int; 2003 Jun; 45(3):307-10. PubMed ID: 12828586
[TBL] [Abstract][Full Text] [Related]
18. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
19. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
[TBL] [Abstract][Full Text] [Related]
20. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
